EntreMed (ENMD) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : EntreMed (ENMD)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Andrew H who wrote (1505)	2/11/1999 8:48:00 PM
From: Pluvia	Read Replies (1) of 2135

<<The fact that the NCI managed to replicate shows that these compounds are indeed volatile and difficult to handle but with the proper care, it can be done.>> A volatile compound is a worthless compound IMO, if it is ever to be mass marketed - should it even show enough promise to be studied in humans. Even with human trial, you are looking at years during which time this stock will crater. Heck these guys don't even have a handle on how to produce the drug - and you're giddy about it? GMAFB Longs typically overlook the problems only focusing on the potential. Reality sets in when the stock goes down and the company goes broke. Longs should thank their luck stars they have the opportunity to exit again with their ass in hand. Cheers Steve

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next